Cargando…
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study
BACKGROUND: Vedolizumab is a gut-selective anti-lymphocyte trafficking agent used to treat ulcerative colitis (UC) and Crohn’s disease. OBJECTIVES: We aimed to evaluate the effectiveness, safety, and durability of the therapeutic effect of vedolizumab after treatment discontinuation in a real-world...
Autores principales: | Eder, Piotr, Kłopocka, Maria, Cichoż-Lach, Halina, Talar-Wojnarowska, Renata, Kopertowska-Majchrzak, Maria, Michalak, Agata, Filip, Rafał, Waszak, Katarzyna, Stawczyk-Eder, Kamila, Janiak, Maria, Skrobot, Krzysztof, Liebert, Ariel, Zatorski, Hubert, Solarska-Półchłopek, Anna, Krogulecki, Michał, Pękała, Anna, Poniewierka, Elżbieta, Smoła, Izabela, Kaczka, Aleksandra, Wojciechowski, Krzysztof, Drygała, Szymon, Zagórowicz, Edyta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932778/ https://www.ncbi.nlm.nih.gov/pubmed/36818601 http://dx.doi.org/10.1177/17562848231151295 |
Ejemplares similares
-
Characteristics of patients with moderate-to-severe ulcerative
colitis treated with vedolizumab: results from a Polish multicenter,
prospective, observational real-life study (the POLONEZ study)
por: Cichoż-Lach, Halina, et al.
Publicado: (2021) -
Polonez
por: Moniuszko, Stanislaw, 1819-1872
Publicado: (1952) -
Polonez, d-dur, [na skrzypce i fortepian]
por: Mlynarski, Emil, 1870-1935
Publicado: (1951) -
Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients
por: Łodyga, Michał, et al.
Publicado: (2021) -
Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2014)